Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials.

Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials.

Item

http://www.wikidata.org/entity/Q34294996

Q34294996

about

Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials Association between non-high-density-lipoprotein-cholesterol levels and the prevalence of asymptomatic intracranial arterial stenosis.Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.Observational study of effects of Saroglitazar on glycaemic and lipid parameters on Indian patients with type 2 diabetes Goal attainments and their discrepancies for low density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apo B) in over 2,000 Chinese patients with known coronary artery disease or type 2 diabetes Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling.Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis.Dyslipidemia in obesity: mechanisms and potential targets Positive correlation between variants of lipid metabolism‑related genes and coronary heart disease.Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome -- a randomized study (SYSDIET).Monitoring of lipids, enzymes, and creatine kinase in patients on lipid-lowering drug therapy Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice.Current Phase II proprotein convertase subtilisin/kexin 9 inhibitor therapies for dyslipidemia.Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis.Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial.Alirocumab Treatment and Achievement of Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials.β-glucans reduce LDL cholesterol in patients with myasthenia gravis.Façons d’identifier et de prendre en charge la dyslipidémie athérogène: Une conséquence métabolique de l’obésité et du diabète.Alirocumab versus usual lipid-lowering care as add-on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trial.Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

P2860

Q34072528-9149097F-D518-43C1-81E1-FA18647A4CDE Q34297213-263EBC52-2D8F-45EA-BD6A-94FC18A2FE72 Q34755882-1769BD92-B08C-47E2-ACCC-11F5CD29E688 Q34804834-BA21B909-8097-46D4-8A6B-16C1E47F584F Q34877739-AB1919CA-E4CA-4812-92FB-4950BD8C2BF1 Q35572154-38125CEE-174E-4251-814A-7D29DBE5316F Q35667311-4F6579DA-E99F-4A3C-8A75-8AC669C103FC Q36047677-3A286206-FAC2-4343-8EF1-5515A40AB61D Q36994072-085F77B9-3B74-4BFC-944E-3815D9D012C7 Q37048550-C92142D2-5D83-4A83-902D-9AB23AE3079B Q37110911-EA68ADAC-6C2B-4011-968C-5B9B9D837C84 Q37115301-D1CA9B64-CDE2-4EEB-A5B6-3E6FB3B2DE51 Q37308578-AB0C05F4-A3F4-45DE-BEE1-D350AB8B738A Q37716347-FC2C31ED-F10E-4879-BDC2-69E49DFECB1B Q38124404-87027EA8-7051-4960-93E0-BF37C46B3CC2 Q38328566-4001DF9F-92A9-4AAC-BA61-AD0B89B58086 Q38452702-3D893097-B9B3-42C6-B910-DE3980463E0C Q38597940-19B3A5FF-7247-4DD4-B178-9BFB6F0EF2F0 Q44403779-7CF4C817-109C-4AD8-9999-73D65CB349BB Q46488015-2C5B1936-9998-483B-85B6-0784AFD396EA Q50047295-B2414EAE-D799-4216-B056-22ED64FEB207 Q58362346-8A7C490F-3C78-449C-B97E-338E65433E0B

P2860

Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials.

Item

http://www.wikidata.org/entity/Q34294996

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu